TP53 mutation and survival in aggressive B cell lymphoma

Author:

Zenz Thorsten123ORCID,Kreuz Markus4,Fuge Maxi3,Klapper Wolfram5,Horn Heike6,Staiger Annette M.6,Winter Doris3,Helfrich Hanne3,Huellein Jennifer1,Hansmann Martin‐Leo7,Stein Harald8,Feller Alfred9,Möller Peter10,Schmitz Norbert11,Trümper Lorenz12,Loeffler Markus4,Siebert Reiner13,Rosenwald Andreas14,Ott German15,Pfreundschuh Michael16,Stilgenbauer Stephan3,

Affiliation:

1. Molecular Therapy in Haematology and Oncology and Department of Translational OncologyNational Center for Tumor Diseases (NCT) and German Cancer Research Center (dkfz)Heidelberg Germany

2. Dept. of Medicine VUniversity Hospital HeidelbergHeidelberg Germany

3. Dept. of Internal Medicine IIIUniversity of UlmUlm Germany

4. Institute for Medical Informatics, Statistics and EpidemiologyUniversität LeipzigLeipzig Germany

5. Institute of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig‐Holstein, Campus KielKiel Germany

6. Department of Clinical PathologyRobert‐Bosch‐Krankenhaus, and Dr. Margarete Fischer‐Bosch‐Institute of Clinical Pharmacology, and University of TübingenStuttgart Germany

7. Dr. Senckenberg Institute of Pathology, Universitätsklinikum FrankfurtFrankfurt Germany

8. Pathodiagnostik BerlinBerlin Germany

9. Institute of Pathology, University Hospital Schleswig‐Holstein, Campus Lübeck, and Hämatopathologie Lübeck Germany

10. Institute of Pathology, Universitätsklinikum UlmUlm Germany

11. Department of Hematology, Oncology and PneumonologyUniversity Hospital of MuensterMuenster Germany

12. Department of Hematology and OncologyGeorg‐August UniversitätGöttingen Germany

13. Institute of Human Genetics, University of UlmUlm Germany

14. Institute of Pathology, and Comprehensive Cancer Center Mainfranken (CCC MF), University of WürzburgWürzburg Germany

15. Department of Clinical PathologyRobert‐Bosch‐KrankenhausStuttgart Germany

16. Internal Medicine I, Saarland University Medical SchoolHomburg Germany

Funder

Institute of Infection and Immunity

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3